Mutant p53 can provoke apoptosis in p53-deficient Hep3B cells with delayed kinetics relative to wild-type p53

Oncogene

Volumn 17, Issue 26, 1998, Pages 3507-3512

  Stähler, Frauke ^a   Roemer, Klaus ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

c Myc; Cell death; p53; Serine protease

Indexed keywords

MUTANT PROTEIN; ONCOPROTEIN; PROTEIN P53; SERINE PROTEINASE INHIBITOR;

APOPTOSIS; ARTICLE; CELL LINE; CELL PROLIFERATION; CONTROLLED STUDY; HEPATOMA CELL; HUMAN; HUMAN CELL; OLIGOMERIZATION; PRIORITY JOURNAL;

EID: 0032585637     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1202245     Document Type: Article

References (29)

1. Allday MJ, Inman GJ, Crawford DH and Farrell PJ. (1995). EMBO J., 14, 4994-5005.
2. Barlow C, Brown KD, Deng C-X, Tagle DA and Wynshaw-Boris A. (1997). Nature Genet., 17, 453-456.
3. Bales S and Vousden KH. (1996). Curr. Opin. Genet. Dev., 6, 12-18.
4. Buckbinder L, Talbott R, Velascomiguel S, Takenaka I, Faha B, Seizinger BR and Kley N. (1995). Nature, 377, 646-649.
5. Caelles C, Helmberg A and Karin M. (1994). Nature, 370, 220-223.
6. Chandler JM, Alnemri ES, Cohen GM and MacFarlane M. (1997). Biochem. J., 15, 19-23.
7. Chen X, Ko LJ, Juyaraman L and Prives C. (1996). Genen Dev., 10, 2438-2451.
8. Debbas M and White ER. (1993). Genes Dev., 7, 546-554.
9. Friedlander P, Haupt Y, Prives C and Oren M. (1996). Mol. Cell. Biol., 16, 4961-4971.
10. Friedman SL, Shaulian E, Littlewood T, Resnitzky D and Oren M. (1997). Oncogene, 15, 63-70.
11. Fuchs EJ, McKenna KA and Bedi A. (1997). Cancer Res., 57, 2550-2554.
12. Haupt Y, Rowan S, Shaulian E, Vousden KH and Oren M. (1995). Genes Dev., 9, 2170-2183.
13. Israeli D, Tessler E, Haupt Y, Elkeles A, Wilder S, Amson R, Telerman A and Oren M. (1997). EMBO J., 16, 4384-4392.
14. Kagaya S, Kitanaka C, Noguchi K, Mochizuki T, Sugiyama A, Asai A, Yasuhara N, Eguchi Y, Tsujimoto Y and Kuchino Y. (1997). Mol. Cell. Biol., 17, 6736-6745.
15. Klefstrom J, Arighi E, Littlewood T, Jäättelä M, Saksela E, Evan GI and Alitalo K. (1997). EMBO J., 16, 7382-7392.
16. Liu Z, Hsu H, Goeddel DV and Karin M. (1996). Cell, 87, 565-576.
17. Ludwig RL, Bates S and Vousden KH. (1996). Mol. Cell. Biol., 16, 4952-4960.
18. Mayo MW, Wang C-Y, Cogswell PC, Rogers-Graham KS, Lowe SW, Der CJ and Baldwin Jr AS. (1997). Science, 278, 1812-1815.
19. Miyashita T and Reed J. (1995). Cell, 80, 293-299.
20. Murphy M, Hinman A and Levine AJ. (1996). Genes Dev., 10, 2971-2980.
21. Müller M, Strand S, Hug H, Heinemann EM, Walezak H, Hofmann WJ, Stremmel W, Krammer PH and Galle PR. (1997). J. Clin. Invest., 99, 403-413.
22. Polyak K, Xia Y, Zweier JL, Kinzler KW and Vogelstein B. (1997). Nature, 389, 300-305.
23. Roemer K and Mueller-Lantzsch N. (1996). Oncogene, 12, 2069-2079.
24. Sabbatini P, Lin JY, Levine AJ and White E. (1995). Genes Dev., 9, 2184-2192.
25. Sakamuro D, Sabbatini P, White E and Prendergast GC. (1997). Oncogene, 15, 887-898.
26. Theis S, Atz J, Mueller-Lantzsch N and Roemer K. (1997). Int. J. Cancer, 71, 858-866.
27. Walker K K and Levine AJ. (1996). Proc. Natl. Acad. Sci. USA, 93, 15335-15340.
28. Yee J-K, Friedmann T and Burns JC. (1994). Methods in Cell Biology. Roth MG (ed). Academic Press: San Diego, pp. 99-112.
29. Yonish-Rouach E, Deguin V, Zaitehouk T, Breugnot C, Mishal Z, Jenkins JR and May E. (1995). Oncogene, 11, 2197-2205.